日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adverse drug reactions among children with tuberculosis in China: a multicentre study, 2017-2022

中国结核病患儿药物不良反应:一项多中心研究,2017-2022年

Zhou, Yiqing; Kan, Yu; Liu, Ping; Xu, Hongmei; Ma, Juan; Li, Haiyan; Yu, Xin; Cai, Qingshan; Tian, Man; Fang, Qing; Zeng, Xianhui; Yang, Guangxu; Yang, Tao; Wang, Fei; Chen, Bin; Martinez, Leonardo

Development and evaluation of multiplex real-time PCR for rapid identifying major pathogenic mycobacteria from pulmonary and extrapulmonary clinical samples in eastern China

开发和评估用于快速鉴定中国东部地区肺部和肺外临床样本中主要致病性分枝杆菌的多重实时PCR方法

Fang, Tingting; Peng, Lijun; Yang, Tingting; Cai, Qingshan; Li, Huanyu; Li, Hao; Cai, Long

Interim efficacy and safety analysis of the regimen containing delamanid in the treatment of multidrug resistant/rifampicin-resistant/extensively drug-resistant tuberculosis: a single-arm, prospective, monocentric, observational study

含德拉马尼方案治疗多重耐药/利福平耐药/广泛耐药结核病的疗效和安全性中期分析:一项单臂、前瞻性、单中心观察性研究

Qin, Yao; Chen, Yuanyuan; Cai, Qingshan

Pediatric drug-sensitive tuberculosis treatment regimen profiles and treatment outcomes in mainland China, 2017-2022: a multi-center study

2017-2022年中国大陆儿童药物敏感性结核病治疗方案概况及治疗结果:一项多中心研究

Zeng, Xinxin; Xu, Hao; Li, Aole; Liu, Juanjuan; Wu, Yuhang; Dong, Xingyu; Yu, Xin; Xu, Hongmei; Liu, Ping; Ma, Juan; Cai, Qingshan; Li, Haiyan; Tian, Man; Fang, Qing; Yang, Guangxu; Wang, Fei; Chen, Bin; Huang, Lisu

AEBP1 inhibition reduces cell growth and PI3K/AKT pathway while less regulates cell mobility in hepatocellular carcinoma.

AEBP1 抑制可降低肝细胞癌的细胞生长和 PI3K/AKT 通路,但对细胞迁移的调节作用较小

Liu Liyou, Cai Qingshan, Wu Dongyang, Li Shudong, Liu Dong, Zheng Jianxing

Incidence and risk factors of abnormal liver function and anti-tuberculosis drug-induced liver injury: a multicenter retrospective study involving 482 chinese pediatric tuberculosis patients

抗结核药物引起的肝损伤及肝功能异常的发生率和危险因素:一项纳入482例中国儿童结核病患者的多中心回顾性研究

Zhou, Yiqing; Wang, Min; Xu, Hongmei; Huang, Lisu; Liu, Ping; Ma, Juan; Li, Haiyan; Yu, Xin; Cai, Qingshan; Tian, Man; Fang, Qing; Zeng, Xianhui; Yang, Guangxu; Yang, Tao; Wang, Fei; Chen, Bin

Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

贝达喹啉、利奈唑胺、左氧氟沙星、氯法齐明和环丝氨酸联合化疗9个月治疗利福平/多重耐药结核病:一项在中国开展的多中心、随机、开放标签非劣效性试验

Song, Yanhua; Shu, Wei; Pei, Yi; Du, Juan; Wu, Guihui; Wang, Hua; Mi, Fengling; Liu, Fangchao; Ma, Liping; Xie, Li; Kong, Zhongshun; Wu, Xiaoguang; Liu, Rongmei; Chen, Hongmei; Li, Hua; Ge, Qiping; Nie, Lihui; Lv, Zizheng; Huang, Xuerui; Li, Mingwu; Jiang, Mingying; Chen, Xiaohong; Cai, Qingshan; Chen, Wei; Liu, Yanmei; Miao, Yanfang; Tang, Yan; Chen, Yu; Geng, Shujun; Zhou, Quanying; Liu, Yuhong; Pang, Yu; Gao, Mengqiu

Correction: Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

更正:贝达喹啉、利奈唑胺、左氧氟沙星、氯法齐明和环丝氨酸化疗治疗利福平/多重耐药结核病九个月:一项在中国开展的多中心、随机、开放标签非劣效性试验

Song, Yanhua; Shu, Wei; Pei, Yi; Du, Juan; Wu, Guihui; Wang, Hua; Mi, Fengling; Liu, Fangchao; Ma, Liping; Xie, Li; Kong, Zhongshun; Wu, Xiaoguang; Liu, Rongmei; Chen, Hongmei; Li, Hua; Ge, Qiping; Nie, Lihui; Lv, Zizheng; Huang, Xuerui; Li, Mingwu; Jiang, Mingying; Chen, Xiaohong; Cai, Qingshan; Chen, Wei; Liu, Yanmei; Miao, Yanfang; Tang, Yan; Chen, Yu; Geng, Shujun; Zhou, Quanying; Liu, Yuhong; Pang, Yu; Gao, Mengqiu

A High Immune-Related Index with the Suppression of cGAS-STING Pathway is a Key Determinant to Herceptin Resistance in HER2+ Breast Cancer

抑制 cGAS-STING 通路导致免疫相关指数升高是 HER2+ 乳腺癌赫赛汀耐药的关键决定因素

Ruizhao Cai, Qingshan Chen, Dechang Zhao, Yan Wang, Ling Zhou, Kaiming Zhang, Jialu Shan, Zhiling Li, Yuhong Chen, Hailiang Zhang, Gongkan Feng, Xiaofeng Zhu, Rong Deng, Jun Tang

Rapid detection of Mycobacterium tuberculosis in sputum using CRISPR-Cas12b combined with cross-priming amplification in a single reaction

利用 CRISPR-Cas12b 结合交叉引物扩增技术,在单次反应中快速检测痰液中的结核分枝杆菌

Peng, Lijun; Fang, Tingting; Cai, Qingshan; Li, Hao; Li, Huanyu; Sun, Haiqiong; Zhu, Mingzhi; Dai, Lingshan; Shao, Yanqin; Cai, Long